{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
INN:oremepermin alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02652455: Early Phase 1 Interventional Completed Melanoma (Skin)
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:solabafusp alfa [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:burfiralimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:rilunermin alfa [INN]
Source URL:
Class:
PROTEIN
Class:
PROTEIN